| (Values in U.S. Thousands) | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | Jun, 2022 |
| Sales | 944,960 | 832,060 | 942,030 | 925,360 | 876,410 |
| Sales Growth | +13.57% | -11.67% | +1.80% | +5.59% | -1.00% |
| Net Income | 127,070 | 54,680 | 120,410 | 135,840 | 60,970 |
| Net Income Growth | +132.39% | -54.59% | -11.36% | +122.80% | -70.15% |
Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Horizon Therapeutics plc is a biopharmaceutical focused on making drugs in arthritis, pain, inflammatory and orphan diseases areas.
Fiscal Year End Date: 12/31